Smith John P DDS in Delavan, Wisconsin
-
Best Shoes for Foot Health: What Podiatrists Recommend in 2025
This 2025 guide translates podiatrists’ latest, evidence-informed advice into clear, trustworthy shoe choices for everyday life. It explains what to prioritize—secure heel counter, adequate arch support, cushioning firmness matched to your activity, a spacious toe box, stable midsole, appropriate heel-to-toe drop, slip-resistant traction, breathable materials, and orthotic compatibility—then tailors recommendations for common needs like plantar fasciitis, bunions, diabetes/neuropathy, arthritis, flat or high arches, pregnancy, and seniors. You’ll find practical fit steps (measure at day’s end, ensure a thumb’s width at the toes, use lacing techniques), guidance on break-in and replacement timelines, and red flags that warrant podiatry follow-up. With lab- and clinic-informed picks across walking, running, and work categories, plus wide sizes and budget-conscious options, the article offers patients, caregivers, and information-seekers a supportive, actionable path to healthier feet.
-
How CMS’s new rural health funding could change access in 2026
CMS has started rolling out the Rural Health Transformation Program, a $50 billion effort meant to help states strengthen rural care. The first-year awards are in place, but patients should expect changes to arrive unevenly and gradually, not all at once.
-
Aurora Sheboygan Prices – CEFAZOLIN 25MG/ML SOLUTION is $77.74
At Aurora Medical Center Sheboygan, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10002800, regarding CEFAZOLIN 25MG/ML SOLUTION, which is classified under revenue code 250 and associated with CPT code J0690, the designated fee stands at $77.74. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Breast Implant Safety in 2026: What the FDA’s Latest Updates Mean for Patients
The FDA continues to monitor rare cancers linked to breast implants, including BIA-ALCL and emerging reports of BIA-SCC. Here’s what patients need to know about symptoms, risk levels, informed consent, and insurance coverage.